全球骨关节炎治疗市场 - 市场规模、份额、成长分析：按类型、按应用划分 - 行业预测（2023-2030）

Global Osteoarthritis Treatment Market Size, Share, Growth Analysis, By Type(Medication, Physical Therapy and Surgical Procedures), By Application(Knee Osteoarthritis, Hip Osteoarthritis) - Industry Forecast 2023-2030

出版日期: 2023年10月11日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2021年全球骨关节炎治疗市场规模为74亿美元，2022年为80.3亿美元。预计该市场在预测期（2023-2030年）将以8.5%的年复合成长率扩张，到2030年达到154.2亿美元。

近年来，由于骨关节炎盛行率上升、人口高龄化以及对有效治疗方案的需求不断增加，全球骨关节炎治疗市场出现了显着增长。医疗保健的进步和预期寿命的提高显着增加了易患骨关节炎的老年人比例。因此，越来越需要创新和有效的治疗方案来控制这些患者的症状并提高生活品质。此外，人们对可用治疗方案和早期疗育重要性的认识的提高进一步促进了市场的成长。医疗保健提供者和组织正在积极努力向患者提供有关骨关节炎、其危险因素以及各种可用治疗方法的教育。这种认识的提高导致了早期诊断和及时开始治疗，从而推动了对骨关节炎治疗产品的需求。

全球肥胖率的上升极大地导致了骨关节炎发病率的增加。随着全球肥胖率持续增加，骨关节炎的盛行率也增加。病例激增推动了对治疗方案的需求，因为肥胖者通常需要采取综合方法来有效管理其病情。

缺乏疾病修正治疗仍然是骨关节炎治疗领域的主要挑战。儘管取得了重大进展，但仍缺乏可以减缓或逆转骨关节炎进展的有效治疗方法。这种限制阻碍了疾病的整体管理并对患者的治疗结果产生负面影响。

该报告研究了全球骨关节炎治疗市场，并提供了市场概述，包括按类型、应用、地区和参与市场的公司概况分類的趋势。

主要企业简介
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- GlaxoSmithKline plc
- Novartis International AG
- AbbVie Inc
- Sanofi
- Eli Lilly and Company
- Merck & Co., Inc.
- Bayer AG
- Bristol Myers Squibb Company
- Ferring Pharmaceuticals
- Boehringer Ingelheim International GmbH
- Teva Pharmaceutical Industries Ltd.
- Flexion Therapeutics, Inc.
- Bioventus LLC
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- Medtronic plc
- Smith &Nephew plc
- DJO Global, Inc.

简介目录

Product Code: SQMIG35A2305

Global Osteoarthritis Treatment Market size was valued at USD 7.4 billion in 2021 and is poised to grow from USD 8.03 billion in 2022 to USD 15.42 billion by 2030, growing at a CAGR of 8.5% during the forecast period (2023-2030).

The global osteoarthritis treatment market has witnessed significant growth in recent years, driven by the rising prevalence of osteoarthritis, an aging population, and the increasing demand for effective treatment options. With advancements in healthcare and improved life expectancy, the proportion of elderly individuals susceptible to osteoarthritis has risen significantly. As a result, there is a growing need for innovative and efficient treatment options to manage the symptoms and improve the quality of life for these patients. Moreover, the rising awareness about the available treatment options and the importance of early intervention has further propelled the market growth. Healthcare providers and organizations are actively engaged in educating patients about osteoarthritis, its risk factors, and the various treatment modalities available. This increased awareness has led to early diagnosis and timely treatment initiation, driving the demand for osteoarthritis treatment products.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Osteoarthritis Treatment Market Segmental Analysis

Global Osteoarthritis Treatment Market is segmented by type, application, and region. Based on type, the market can be segmented into Medications, Physical Therapy and Surgical Procedures. Based on application, the market is segmented into Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Spine Osteoarthritis, Shoulder Osteoarthritis and Foot and Ankle Osteoarthritis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Osteoarthritis Treatment Market Dynamics

Drivers of the Global Osteoarthritis Treatment Market

Rising Obesity Rates

The escalating global rates of obesity contribute significantly to the increased occurrence of osteoarthritis. As obesity continues to rise worldwide, there is a growing prevalence of osteoarthritis cases. This surge in cases drives the demand for treatment options as obese individuals often require comprehensive approaches to manage their condition effectively.

Restraints in the Global Osteoarthritis Treatment Market

Lack of Disease-Modifying Therapies

The absence of disease-modifying therapies remains a significant challenge in the field of osteoarthritis treatment. Despite notable advancements, there is still a lack of effective therapies capable of slowing down or reversing the progression of osteoarthritis. This limitation impedes the overall management of the disease and negatively impacts treatment outcomes for patients.

Market Trends of the Global Osteoarthritis Treatment Key

A key market trend in the global Osteoarthritis Treatment market is the growing emphasis on personalized and multimodal approaches to manage the condition. Osteoarthritis is a degenerative joint disease that affects a significant portion of the global population, particularly the elderly. Traditionally, treatment approaches have focused on pain management and symptom relief through nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics. However, there is an increasing recognition that a one-size-fits-all approach may not be effective for all patients.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Osteoarthritis Treatment Market by Type
- Market Overview
- Medication
- Physical Therapy and Surgical Procedures
Global Osteoarthritis Treatment Market by Application
- Market Overview
- Knee Osteoarthritis
- Hip Osteoarthritis
- Hand Osteoarthritis
- Spine Osteoarthritis
- Shoulder Osteoarthritis and Foot and Ankle Osteoarthritis
Global Osteoarthritis Treatment Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Pfizer Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Johnson & Johnson Services, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GlaxoSmithKline plc (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Novartis International AG (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- AbbVie Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eli Lilly and Company (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck & Co., Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bayer AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bristol Myers Squibb Company (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ferring Pharmaceuticals (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Boehringer Ingelheim International GmbH (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Flexion Therapeutics, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bioventus LLC (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Zimmer Biomet Holdings, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Stryker Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medtronic plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Smith & Nephew plc (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- DJO Global, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments